BP Ousted Chairman Albert Manifold Disputes Misconduct Allegations UK Exports to US Plunge 25 as Trumps Liberation Day Tariffs Reshape Trade Flows General Compute Launches First ASICNative Neocloud for AI Agent Applications The Hidden Risk of PropertyDependent Retirement Aging Homes and Depreciating Values States Escalate Legal Battle Against Prediction Markets as Regulatory Clash Intensifies US Stock Futures and Bond Yields Decline Amid Reports of Putins Updated Nuclear Doctrine Kingstone Companies Inc KINS Q1 2026 Earnings Major Earnings Miss of 32 Below Estimates PGY Q1 2026 Earnings Massive EPS Beat Drives Investor Interest Despite Share Dip CATX Q1 2026 Earnings Narrower Loss Fails to Lift PreRevenue Biotech CDP Q1 2026 Earnings EPS Slightly Above Estimates Amid Defense Portfolio Stability Guardian Pharmacy Services Inc GRDN Q1 2026 Earnings EPS Misses Estimates as Pharmacy Operations Face Margin Pressure OGE Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Headwinds American Realty Investors Inc ARL Holds Steady at 1418 as Key Levels Define NearTerm Trading Range Autolus Therapeutics AUTL Edges Higher Testing Resistance Near 181 Restaurant Brands International QSR Holds Steady Near Support Amid Sector Uncertainty Washington Trust Bancorp WASH Holds Near Support as Slight Dip Tests Key Levels ProQR Therapeutics PRQR Soars 83 Analyzing the Rally and Key Levels to Watch VLN Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Uncertainties CGNX Q1 2026 Earnings Robust EPS Surprise Overshadowed by Revenue Disappointment VLTO Q1 2026 Earnings EPS Beat of 435 Fails to Lift Shares as Revenue Details Remain Unclear ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase MFC Q1 2026 Earnings EPS Misses Estimates Amid Subdued Market Reaction ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss FIS Secures Major Client Wins Signaling Potential Turnaround Momentum CHDN Q1 2026 Earnings EPS Beats Estimates by 182 Stock Edges Lower Apollomics Inc Warrant APLMW Holds Steady Near Minimal Levels A Closer Look at the Biotech Derivative